Andersen ME, Hagenbuch B, Apte U, Corton JC, Fletcher T, Lau C, Roth WL, Staels B, Vega GL, Clewell HJ, Longnecker MP (2021) Why is elevation of serum cholesterol associated with exposure to perfluoroalkyl substances (PFAS) in humans? A workshop report on potential mechanisms. Toxicology 459:152845

Article  CAS  PubMed  Google Scholar 

Ashby J, Brady A, Elcombe CR, Elliott BM, Ishmael J, Odum J, Tugwood JD, Kettle S, Purchase IF (1994) Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis. Hum Exp Toxicol 13(Suppl 2):S1-117

Article  PubMed  Google Scholar 

Azuma H, Paulk N, Ranade A, Dorrell C, Al-Dhalimy M, Ellis E, Strom S, Kay MA, Finegold M, Grompe M (2007) Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice. Nat Biotechnol 25(8):903–910

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baraldo M (2008) The influence of circadian rhythms on the kinetics of drugs in humans. Expert Opin Drug Metab Toxicol 4(2):175–192

Article  CAS  PubMed  Google Scholar 

Beggs KM, McGreal SR, McCarthy A, Gunewardena S, Lampe JN, Lau C, Apte U (2016) The role of hepatocyte nuclear factor 4-alpha in perfluorooctanoic acid- and perfluorooctanesulfonic acid-induced hepatocellular dysfunction. Toxicol Appl Pharmacol 304:18–29

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bentley P, Calder I, Elcombe C, Grasso P, Stringer D, Wiegand HJ (1993) Hepatic peroxisome proliferation in rodents and its significance for humans. Food Chem Toxicol 31(11):857–907

Article  CAS  PubMed  Google Scholar 

Blake BE, Fenton SE (2020) Early life exposure to per- and polyfluoroalkyl substances (PFAS) and latent health outcomes: a review including the placenta as a target tissue and possible driver of peri- and postnatal effects. Toxicology 443:152565

Article  CAS  PubMed  Google Scholar 

Brennan NM, Evans AT, Fritz MK, Peak SA, von Holst HE (2021) Trends in the regulation of per- and polyfluoroalkyl substances (PFAS): a scoping review. Int J Environ Res Public Health 18(20):10900

Article  PubMed  PubMed Central  Google Scholar 

Butenhoff J, Costa G, Elcombe C, Farrar D, Hansen K, Iwai H, Jung R, Kennedy G Jr, Lieder P, Olsen G, Thomford P (2002) Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months. Toxicol Sci 69(1):244–257

Article  CAS  PubMed  Google Scholar 

Chang ET, Adami HO, Boffetta P, Cole P, Starr TB, Mandel JS (2014) A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and cancer risk in humans. Crit Rev Toxicol 44(Suppl 1):1–81

Article  CAS  PubMed  Google Scholar 

Chappell GA, Thompson CM, Wolf JC, Cullen JM, Klaunig JE, Haws LC (2020) Assessment of the mode of action underlying the effects of GenX in mouse liver and implications for assessing human health risks. Toxicol Pathol 48(3):494–508

Article  CAS  PubMed  PubMed Central  Google Scholar 

Conley JM, Lambright CS, Evans N, Medlock-Kakaley E, Hill D, McCord J, Strynar MJ, Wehmas LC, Hester S, MacMillan DK, Gray LE Jr (2022) Developmental toxicity of Nafion byproduct 2 (NBP2) in the Sprague-Dawley rat with comparisons to hexafluoropropylene oxide-dimer acid (HFPO-DA or GenX) and perfluorooctane sulfonate (PFOS). Environ Int 160:107056

Article  CAS  PubMed  Google Scholar 

Corton JC, Cunningham ML, Hummer BT, Lau C, Meek B, Peters JM, Popp JA, Rhomberg L, Seed J, Klaunig JE (2014) Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPARalpha) as a case study. Crit Rev Toxicol 44(1):1–49

Article  CAS  PubMed  Google Scholar 

Corton JC, Peters JM, Klaunig JE (2018) The PPARalpha-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions. Arch Toxicol 92(1):83–119

Article  CAS  PubMed  Google Scholar 

de la Rosa Rodriguez MA, Sugahara G, Hooiveld G, Ishida Y, Tateno C, Kersten S (2018) The whole transcriptome effects of the PPARalpha agonist fenofibrate on livers of hepatocyte humanized mice. BMC Genom 19(1):443

Article  Google Scholar 

Domingo JL, Nadal M (2019) Human exposure to per- and polyfluoroalkyl substances (PFAS) through drinking water: a review of the recent scientific literature. Environ Res 177:108648

Article  CAS  PubMed  Google Scholar 

Fenton SE, Ducatman A, Boobis A, DeWitt JC, Lau C, Ng C, Smith JS, Roberts SM (2021) Per- and polyfluoroalkyl substance toxicity and human health review: current state of knowledge and strategies for informing future research. Environ Toxicol Chem 40(3):606–630

Article  CAS  PubMed  Google Scholar 

Foquet L, Schafer C, Minkah NK, Alanine DGW, Flannery EL, Steel RWJ, Sack BK, Camargo N, Fishbaugher M, Betz W, Nguyen T, Billman ZP, Wilson EM, Bial J, Murphy SC, Draper SJ, Mikolajczak SA, Kappe SHI (2018) Plasmodium falciparum liver stage infection and transition to stable blood stage infection in liver-humanized and blood-humanized FRGN KO mice enables testing of blood stage inhibitory antibodies (reticulocyte-binding protein homolog 5) in vivo. Front Immunol 9:524

Article  PubMed  PubMed Central  Google Scholar 

Frisbee SJ, Shankar A, Knox SS, Steenland K, Savitz DA, Fletcher T, Ducatman AM (2010) Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project. Arch Pediatr Adolesc Med 164(9):860–869

Article  PubMed  PubMed Central  Google Scholar 

Fu J, Gao Y, Cui L, Wang T, Liang Y, Qu G, Yuan B, Wang Y, Zhang A, Jiang G (2016) Occurrence, temporal trends, and half-lives of perfluoroalkyl acids (PFAAs) in occupational workers in China. Sci Rep 6:38039

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gebbink WA, van Leeuwen SPJ (2020) Environmental contamination and human exposure to PFASs near a fluorochemical production plant: review of historic and current PFOA and GenX contamination in the Netherlands. Environ Int 137:105583

Article  CAS  PubMed  Google Scholar 

Guillette TC, McCord J, Guillette M, Polera ME, Rachels KT, Morgeson C, Kotlarz N, Knappe DRU, Reading BJ, Strynar M, Belcher SM (2020) Elevated levels of per- and polyfluoroalkyl substances in Cape Fear River Striped Bass (Morone saxatilis) are associated with biomarkers of altered immune and liver function. Environ Int 136:105358

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gunewardena S, Huck I, Walesky C, Robarts D, Weinman S, Apte U (2022) Progressive loss of hepatocyte nuclear factor 4 alpha activity in chronic liver diseases in humans. Hepatology 76(2):372–386

Article  CAS  PubMed  Google Scholar 

Guo H, Sheng N, Guo Y, Wu C, Xie W, Dai J (2021) Exposure to GenX and its novel analogs disrupts fatty acid metabolism in male mice. Environ Pollut 291:118202

Article  CAS  PubMed  Google Scholar 

He Y, Lv D, Li C, Liu X, Liu W, Han W (2022) Human exposure to F-53B in China and the evaluation of its potential toxicity: An overview. Environ Int 161:107108

Article  CAS  PubMed  Google Scholar 

Hopkins ZR, Sun M, DeWitt JC, Knappe DRU (2018) Recently detected drinking water contaminants: GenX and other per- and polyfluoroalkyl ether acids. J AWWA 110(7):13–28

Article  CAS  Google Scholar 

Klaunig JE, Babich MA, Baetcke KP, Cook JC, Corton JC, David RM, DeLuca JG, Lai DY, McKee RH, Peters JM, Roberts RA, Fenner-Crisp PA (2003) PPARalpha agonist-induced rodent tumors: modes of action and human relevance. Crit Rev Toxicol 33(6):655–780

Article  CAS  PubMed  Google Scholar 

Kurwadkar S, Dane J, Kanel SR, Nadagouda MN, Cawdrey RW, Ambade B, Struckhoff GC, Wilkin R (2022) Per- and polyfluoroalkyl substances in water and wastewater: a critical review of their global occurrence and distribution. Sci Total Environ 809:151003

Article  CAS  PubMed  Google Scholar 

Lau C (2012) Perfluorinated compounds. In: Luch A (ed) Molecular, clinical and environmental toxicology, vol 3, 1st edn. Springer, Basel, pp 47–86